Compositions for modulating C9ORF72 expression
US10138482B2 · kind B2 · utility
9Cited by
1References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 12, 2017 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | Jan 12, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for reducing expression of C9ORF72 mRNA and protein in an animal. Such methods are useful to treat, prevent, ameliorate, or slow progression of neurodegenerative diseases in an individual in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.